‘Hostile, but hooked’: What’s behind the US-China trade truce extension?

The US and China extended their October 2025 trade truce for only two months, preserving temporary relief from tariff escalation and delaying additional Chinese rare-earth export restrictions, but analysts see little prospect of a durable agreement. Chinese exports to the US still face 36.5% tariffs and US goods entering China face 31% levies, leaving material inflation, margin and supply-chain risks if the truce fails. China retains significant leverage through its control of 60% of known rare-earth deposits and 90% of processing, while disputes over technology controls, Russian-oil sanctions and Taiwan—including an $11.1bn US arms sale—remain major risks to renewed escalation.

Analysis

The market implication is less a broad China-risk repricing than a dated volatility event around the next licensing deadline. US industrial, defense and semiconductor supply chains remain exposed to processing concentration rather than ore availability; the highest sensitivity sits with permanent-magnet components, specialty alloys and downstream electronics. That creates a relative winner set in non-China processing capacity—MP Materials (MP), Lynas Rare Earths (LYC.AX)—while diversified defense primes may face working-capital pressure and production delays before any revenue loss becomes visible.

For the next 1-3 months, tariff stability modestly reduces near-term goods-inflation and importer margin risk, supporting XLI and selected consumer discretionary importers at the margin. But the short duration means companies are unlikely to alter sourcing or capex plans, limiting the earnings multiple benefit; markets should discount any apparent de-escalation unless it is followed by verifiable export-license approvals, shipment volumes and a longer tariff standstill. A renewed restriction would transmit first through spot magnet/material pricing and lead times, then through industrial guidance over one to two quarters.

Consensus may be too focused on headline tariff rates and underweight the asymmetry of supply-chain disruption. A narrow critical-minerals action can impair high-value US production far more quickly than it harms Chinese aggregate exports, especially where inventory buffers are low. Conversely, MP is not a clean immediate hedge: its valuation already embeds strategic-supply optimism, and the thesis depends on ramp execution, customer qualification and contracted downstream volumes rather than geopolitical headlines alone.

The key falsifiers are a durable agreement covering technology controls and predictable mineral licensing, or evidence that OEM inventories and alternate supply are sufficient to absorb a disruption. Escalation risks are non-linear: an additional sanctions package, technology-control expansion or Taiwan-related event can reprice China-exposed cyclicals within days, while a credible multi-quarter framework would compress geopolitical premia over 6-18 months.

Key Decisions for Investors

• Establish a small 1-3 month hedge: long MP versus short XLI, sized at 1:1 beta-adjusted notional. The pair benefits if critical-mineral restrictions return; stop if confirmed licensing/shipment data extend beyond the next deadline or MP processing-ramp guidance deteriorates. Treat as event-risk insurance, not a core position.
• Use options rather than directional semiconductor shorts: buy 2-3 month SMH put spreads only if trade-sensitive semiconductor equipment and industrial names fail to price renewed export-control risk. Target a 2:1 payoff structure; do not initiate without checking implied volatility versus the prior tariff-escalation window.
• Maintain tactical exposure to US industrials only through firms with disclosed North American sourcing and pricing power; avoid adding to low-margin import-dependent manufacturers until the duration and coverage of tariff relief are clarified. The relevant earnings catalyst is next-quarter gross-margin guidance, not summit rhetoric.
• Set alerts for verified rare-earth license approvals, customs shipment data and magnet lead-time quotes. If shipments normalize and a multi-quarter framework emerges, cover the MP/XLI hedge and consider a long XLI rebound trade; absent those data, do not underwrite a durable détente.